11 Fibromyalgia Clinical Trials in Chicago, IL (2026)

Q: How do I join a clinical trial in Chicago?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you.

Recruiting Fibromyalgia Studies in Chicago

NCT05382572Recruiting

Pulmonary Fibrosis Foundation Community Registry

Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary...

Chicago, IL10,000 participantsPulmonary Fibrosis Foundation

View Study Details

NCT02544022Recruiting

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Background: People with neurofibromatosis 1 (NF1) who have plexiform neurofibromas (pNFs) can have pain that affects their daily lives. This study aims to improve questionnaires that measure their pa...

Chicago, IL476 participantsNational Cancer Institute (NCI)

View Study Details

NCT07357727Recruiting

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

The purpose of this trial is to evaluate whether treatment with pelabresib in combination with ruxolitinib leads to improved clinical outcomes compared to ruxolitinib alone in patients with primary my...

Chicago, ILPHASE3460 participantsNovartis Pharmaceuticals

View Study Details

NCT06654752Recruiting

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for t...

Chicago, ILNA430 participantsUniversity of Washington, the Collaborative Health Studies Coordinating Center

View Study Details

NCT06188741Recruiting

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Plexiform neurofibromas (PN) are known to cause significant morbidity in children with NF1. The recent FDA approval for selumetinib in children 2 years and older with inoperable symptomatic PN was bas...

Chicago, ILPHASE2200 participantsUniversity of Alabama at Birmingham

View Study Details

NCT05571059Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF....

Chicago, ILPHASE2128 participantsCumberland Pharmaceuticals

View Study Details

NCT06919042Recruiting

Shockwave in Postoperative Breast Reconstruction Fibrosis

This study evaluates the potential for extracorporeal shockwave therapy to reduce post-operative soft tissue fibrosis....

Chicago, ILNA100 participantsNorthwestern University

View Study Details

NCT00515567Recruiting

Explanted Lung Tissues With Pulmonary Fibrosis

The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level....

Chicago, IL90 participantsUniversity of Chicago

View Study Details

NCT07286188Recruiting

Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy

The goal of this double blinded randomized control trial is to evaluate the impact of misoprostol on fluid deficit during hysteroscopic myomectomies. The main questions it aims to answer are: Is ther...

Chicago, ILPHASE440 participantsNorthwestern University

View Study Details

NCT05248230Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis....

Chicago, ILPHASE230 participants4D Molecular Therapeutics

View Study Details

NCT06541847Recruiting

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with pr...

Chicago, ILPHASE225 participantsHealx Limited

View Study Details

About Fibromyalgia Clinical Trials in Chicago

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 11 fibromyalgia clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 11,979 participants. Research is being sponsored by Pulmonary Fibrosis Foundation, National Cancer Institute (NCI), Novartis Pharmaceuticals and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in Chicago — FAQ

Are there fibromyalgia clinical trials in Chicago?

Yes, there are 11 fibromyalgia clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 11 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated October 21, 2026 from ClinicalTrials.gov